Identification of type II and type III pyoverdine receptors from Pseudomonas aeruginosa

被引:73
|
作者
de Chial, M
Ghysels, B
Beatson, SA
Geoffroy, V
Meyer, JM
Pattery, T
Baysse, C
Chablain, P
Parsons, YN
Winstanley, C
Cordwell, SJ
Cornelis, P
机构
[1] Free Univ Brussels VIB, Lab Microbial Interact, B-1050 Brussels, Belgium
[2] Univ Oxford, MRC, Funct Genet Unit, Dept Human Anat & Genet, Oxford OX1 3QX, England
[3] Univ Strasbourg, Lab Microbiol & Genet, UPRES A 7010, F-67000 Strasbourg, France
[4] Univ Liverpool, Dept Med Microbiol & Genitourinary Med, Liverpool L69 3GA, Merseyside, England
[5] Australian Proteome Anal Facil, Sydney, NSW 2109, Australia
来源
MICROBIOLOGY-SGM | 2003年 / 149卷
关键词
D O I
10.1099/mic.0.26136-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pseudomonas aeruginosa produces, under conditions of iron limitation, a high-affinity siderophore, pyoverdine (PVD), which is recognized at the level of the outer membrane by a specific TonB-dependent receptor, FpvA. So far, for P. aeruginosa, three different PVDs, differing in their peptide chain, have been described (types I-III), but only the FpvA receptor for type I is known. Two PVD-producing P. aeruginosa strains, one type II and one type III, were mutagenized by a mini-TnphoA3 transposon. In each case, one mutant unable to grow in the presence of the strong iron chelator ethylenediaminedihydroxyphenylacetic acid (EDDHA) and the cognate PVD was selected. The first mutant, which had an insertion in the pvdE gene, upstream of fpvA, was unable to take up type II PVD and showed resistance to pyocin S3, which is known to use type II FpvA as receptor. The second mutant was unable to take up type III PVD and had the transposon insertion in fpvA. Cosmid libraries of the respective type II and type III PVD wild-type strains were constructed and screened for clones restoring the capacity to grow in the presence of PVD. From the respective complementing genomic fragments, type II and type III fpvA sequences were determined. When in trans, type II and type III fpvA restored PVD production, uptake, growth in the presence of EDDHA and, in the case of type II fpvA, pyocin S3 sensitivity. Complementation of fpvA mutants obtained by allelic exchange was achieved by the presence of cognate fpvA in trans. All three receptors posses an N-terminal extension of about 70 amino acids, similar to FecA of Escherichia coli, but only FpvAI has a TAT export sequence at its N-terminal end.
引用
收藏
页码:821 / 831
页数:11
相关论文
共 50 条
  • [21] Structure and Function of the Type III Secretion System of Pseudomonas aeruginosa
    Galle, Marlies
    Carpentier, Isabelle
    Beyaert, Rudi
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2012, 13 (08) : 831 - 842
  • [22] The type III secretion system of Pseudomonas aeruginosa: infection by injection
    Alan R. Hauser
    Nature Reviews Microbiology, 2009, 7 : 654 - 665
  • [23] The effect of pmpR on the type III secretion system in Pseudomonas aeruginosa
    Liang HaiHua
    Kong WeiNa
    Shen Tuo
    Duan JiaLi
    Duan KangMin
    CHINESE SCIENCE BULLETIN, 2012, 57 (19): : 2413 - 2418
  • [24] Discovery and Characterization of Inhibitors of Pseudomonas aeruginosa Type III Secretion
    Aiello, Daniel
    Williams, John D.
    Majgier-Baranowska, Helena
    Patel, Ishan
    Peet, Norton P.
    Huang, Jin
    Lory, Stephen
    Bowlin, Terry L.
    Moir, Donald T.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) : 1988 - 1999
  • [25] The type III secretion system of Pseudomonas aeruginosa: infection by injection
    Hauser, Alan R.
    NATURE REVIEWS MICROBIOLOGY, 2009, 7 (09) : 654 - 665
  • [26] Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway
    Yahr, TL
    Goranson, J
    Frank, DW
    MOLECULAR MICROBIOLOGY, 1996, 22 (05) : 991 - 1003
  • [27] Detection of Pseudomonas aeruginosa type III antibodies in children with tracheostomies
    Rao, AR
    Splaingard, MS
    Gershan, WM
    Havens, PL
    Thill, A
    Barbieri, JT
    PEDIATRIC PULMONOLOGY, 2005, 39 (05) : 402 - 407
  • [28] Biofilms and type III secretion are not mutually exclusive in Pseudomonas aeruginosa
    Mikkelsen, H.
    Bond, N. J.
    Skindersoe, M. E.
    Givskov, M.
    Lilley, K. S.
    Welch, M.
    MICROBIOLOGY-SGM, 2009, 155 : 687 - 698
  • [29] Identification of XcpP domains that confer functionality and specificity to the Pseudomonas aeruginosa type II secretion apparatus
    Gérard-Vincent, M
    Robert, V
    Ball, G
    Bleves, S
    Michel, GPF
    Lazdunski, A
    Filloux, A
    MOLECULAR MICROBIOLOGY, 2002, 44 (06) : 1651 - 1665
  • [30] Type II Toxin-Antitoxin Systems in Pseudomonas aeruginosa
    Li, Meng
    Guo, Nannan
    Song, Gaoyu
    Huang, Yi
    Wang, Lecheng
    Zhang, Yani
    Wang, Tietao
    TOXINS, 2023, 15 (02)